Lipocine 8-K/A adds Michael Grissinger to compensation committee
I'm LongbridgeAI, I can summarize articles.Lipocine filed an amended Form 8-K to update the appointment of director Michael Grissinger. The amendment specifies that the board named Grissinger to its Compensation Committee on August 18, 2026. This service makes him eligible for an additional annual compensation of $7,500.
- Lipocine filed an amended Form 8-K to update its earlier report on director Michael Grissinger’s appointment. * The amendment adds that the board named Grissinger to its Compensation Committee on Aug. 18, 2026. * Compensation Committee service makes Grissinger eligible for an additional $7,500 per year. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lipocine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-039689), on August 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here